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Abstract
Objective: To evaluate the association between fatty acid (a-linolenic acid (ALA),
EPA, DHA, palmitic, stearic, oleic, linoleic and arachidonic acids) intake and
prospective weight change in the Heidelberg cohort of the European Prospective
Investigation into Cancer and Nutrition.
Design: Prospective cohort study with mean follow-up time of 6?5 years. In a total
of 9182 men and 10 867 women aged 35 to 64 years, from body weight mea-
surement at recruitment and calibrated body weight during follow-up, weight
change was expressed as mean annual weight change relative to baseline weight
(%/year) and categorised into four groups (weight loss, ,22?5%/5 years; stable
weight, between 22?5 and 12?5%/5 years; small weight gain, $ 2?5 to ,7?5%/5
years; large weight gain, $ 7?5%/5 years). Energy-adjusted dietary fatty acid
intake data were estimated from the FFQ completed at baseline. Multivariate
linear regression models as well as multinomial logistic regression analyses
(carbohydrate replacement models) were conducted.
Results: Stearic acid intake was linearly associated with weight gain (P, 0?01) in
men and women. Linear associations also existed for ALA and arachidonic acid
intake, significantly so in women. In multinomial models, women in the highest
tertile of ALA and stearic acid intake showed increased OR (95% CI) for small
weight gain (1?16 (0?94, 1?88) and 1?24 (1?08, 1?43), respectively), and large
weight gain (1?39 (1?03, 1?88) and 1?56 (1?27, 1?90), respectively), whereas OR
were non-significantly increased in men. Dietary intake of ALA was inversely
associated with large (0?80 (0?65, 0?99)) weight gain in women only.
Conclusions: These results suggest differential effects of single dietary fatty acids
on prospective weight gain in adults.
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The prevalence of overweight and obesity has increased
remarkably during the past 20 years in Germany and
worldwide(1,2). Two-thirds of all obese adults have devel-
oped obesity during adulthood(3). Since the proportion of
overweight people is lowest at the age of 18–19 years(4),
maintenance of the body weight after adolescent growth
should be the primary aim of obesity prevention in adults(5).
In principle, weight change occurs when there is an
imbalance between energy intake and energy expendi-
ture over a longer time period. Psychosocial or genetic
factors favouring excess energy intake and reduced
energy expenditure can contribute to a positive energy
balance eventually leading to weight gain(6). Established
determinants of weight change are alcohol consumption,
smoking habits, sociodemographic factors, physical
activity, mental stress, voluntary weight loss or dieting
behaviour(7). The role of diet in weight change is com-
plex and still many aspects remain to be elucidated. Fat is
the most energy-dense macronutrient providing 38 kJ/g
(9 kcal/g) and high-fat foods are characterised by
enhanced flavour and palatability, while having a less
satiating effect per kilojoule than low-fat foods rich in
protein or complex carbohydrates; thus, a diet with a high
proportion of fat is prone to lead to overconsumption of
energy(8). Although long-chain fatty acids differ only
slightly with respect to the energy content, they can vary
in their effect on energy balance. Both energy expendi-
ture and satiety, which influence the magnitude of excess
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energy intake, have been shown to be affected by the
diet’s fatty acid composition(9). The mechanisms by which
the fatty acids may impact on energy expenditure include
their effect on postprandial thermogenesis(10), fat oxida-
tion rate(11,12) and the sympathetic activity(13). So far,
observational studies in human subjects have investigated
whether different types of fatty acids (i.e. PUFA v. MUFA
v. SFA) differ in their effect on body weight(8,14) or weight
change(15). However, data from experimental studies
suggest that the effects of individual fatty acids are not
necessarily uniform(16). Therefore, in the present study,
the hypothesis that individual fatty acids have differential
effects on long-term weight change was tested within a
prospective cohort study, the Heidelberg cohort of the
European Prospective Investigation into Cancer and
Nutrition (EPIC-Heidelberg). On the basis of the results of
such observational studies, properly designed metabolic/
intervention studies should follow.
Participants and methods
Study population and data collection
The EPIC-Heidelberg comprises 11 928 men (aged 40–64
years) and 13 612 women (aged 35–64 years), recruited
between 1994 and 1998 (66 626 volunteers were con-
tacted, overall participation rate was 38?3%). Habitual
dietary intake during the 12 months preceding the
recruitment was assessed by a validated self-administered
158-item semi-quantitative FFQ including additional
questions with regard to the type of fat for cooking and
fat content of milk and milk products(17). Food coding
and calculation of the individual intake of fatty acids and
other nutrients were carried out using the German Food
Code (version II.3)(18). Information on lifestyle factors
such as educational attainment, smoking habits and
physical activity was assessed by self-administered ques-
tionnaires and a personal computer-guided interview at
baseline. During the participant’s visit in the study centre,
body weight was measured on digital scales (Soehnle,
type 7720/23, Murrhardt, Germany), and height was
measured using a flexible anthropometer by educated
interviewers. In the follow-up questionnaires, which are
mailed to the participants at regular intervals, participants
were asked to report their current body weight. The
participation rates during the follow-ups were above
90% at all times. The study was approved by the local
ethics committee and all participants gave their informed
consent.
Calibration of self-reported body weight at
follow-up
To correct for biases in the self-reported weight, to data
from the three follow-up rounds, a calibration method
was applied, as described by Spencer et al.(19), using data
from the subsample of volunteers who participated in the
24 h dietary recalls conducted by trained interviewers at
baseline (n 2121). During the recalls, participants gave
self-reported information on their body weight at base-
line. In a simple regression analysis, measured weight
was modelled as a function of age and self-reported
weight, stratified by sex and standard BMI categories
(,25, 25–29?9, $30 kg/m2). The obtained equations were
used to calibrate the self-reported weight data of the
follow-up, assuming a consistency in bias in the self-
reported values at baseline and follow-up. Comparison of
reported and calibrated follow-up weight revealed that,
on average, men tended to underestimate their follow-up
weight less than women: the mean difference between
calibrated and reported weight was 0?72 (SD 0?59), 0?67
(SD 0?60), 0?65 kg (SD 0?60) in men and 1?07 (SD 0?70), 1?03
(SD 0?70), 0?98 kg (SD 0?68) in women, in the first
(1998–2000), second (2001–2004) and third (2004–2007)
follow-up, respectively.
Statistical analyses
Follow-up time was defined as the time between baseline
interview and last follow-up contact. Weight change was
calculated as the difference between calibrated self-
reported body weight at the last completed follow-up and
measured body weight at baseline. For the analysis,
annual weight change was expressed as a percentage of
baseline body weight to take into account that absolute
weight change is strongly dependent on baseline weight.
Four categories of weight change in the percentage of
baseline weight were defined as follows: stable body
weight (weight change between 22?5 and 12?5%/5
years); weight loss (weight change ,22?5%/5 years);
small weight gain (weight change of $2?5 to ,7?5%/5
years) and large weight gain (weight change $7?5%/5
years). Change in smoking status between baseline and
last follow-up was accounted for as follows: smokers
at baseline and last follow-up (‘habitual smokers’), non-
smokers at both assessment periods (‘habitual non-
smokers’), smokers at baseline, reporting non-smoking at
follow-up (‘quitters’) and non-smokers at baseline and
reporting smoking at follow-up (‘new smokers’). Physical
activity was classified into four categories (inactive,
moderately inactive, moderately active and active), com-
bining both occupational and recreational activities(20).
All nutrient values were energy-adjusted by the resi-
dual method as described by Willett and Stampfer(21). The
association between fatty acid intake (palmitic, stearic,
oleic, linoleic, arachidonic, a-linolenic acid (ALA), EPA
and DHA) and prospective weight change was investi-
gated using linear and multinomial logistic regression
models. In multiple linear regression analyses, a 5-year
weight change was modelled as a continuous dependent
variable. Nutrient intakes were entered as continuous
independent variables into the model. Participants who
lost more than 2?5% of their baseline weight (weight
losers) during 5 years of follow-up were excluded from
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this analysis to focus on weight gain. In a subanalysis,
only participants with normal weight (BMI between 18?5
and 25 kg/m2) at baseline were included.
For the multinomial logistic regression, generalised
logits were modelled for the three weight change cate-
gories v. stable weight. OR and 95% CI were calculated
by tertiles of fatty acid intake with the lowest tertile being
the reference category. Risk estimates for small and large
gain are given in the Results section (results for weight
loss are not shown). A test for trend across increasing
tertiles of fatty acid intake was performed by entering
median intake values of the fatty acid tertiles as a con-
tinuous variable in the multivariate models. In the multi-
nomial logistic regression analysis, weight change is
treated as a categorical outcome variable. Participants
with stable weight are considered the outcome reference
corresponding to non-diseased participants in classical
binary logistic regression models. The OR can be inter-
preted as the relative risk to fall into a certain weight
change category according to tertiles of dietary fatty acid
intake with the lowest tertile being the reference.
Isoenergetic nutrient residual models were created by
entering the energy-adjusted intakes of all fatty acids of
interest (as continuous variable or tertile categories for the
linear and multinomial logistic regression, respectively)
simultaneously together with the intake of other SFA, other
MUFA, other PUFA, protein and alcohol, as well as total
energy intake. The coefficients derived from these models
represent the effect of substituting energy from carbohy-
drates by energy from a specific fatty acid(22). As intake of
EPA and DHA was highly correlated (r.0?97), their intake
was entered into the model as the sum of both. All models
were adjusted for weight and height at baseline, age, phy-
sical activity, education, change in smoking status and
length of follow-up. In women, multivariate models were
additionally adjusted for menopausal status at baseline
(premenopausal, perimenopausal, postmenopausal, surgical
menopausal and missing information). The analyses were
repeated with a model representing the effect of substituting
energy from MUFA by energy from specific fatty acids
(adjusted for intakes of other PUFA, other SFA, carbohy-
drates, protein, alcohol and total energy). In contrast to the
carbohydrate replacement model in the MUFA replacement
model, the proportion of energy from fat is held constant.
In a final approach, incident overweight and obesity,
respectively, were treated as outcomes in a binary logistic
regression. Participants were defined as incident over-
weight or obese if they had a BMI ,25 or ,30 kg/m2,
respectively, at baseline and a BMI of $25 or $30 kg/m2,
respectively, at last follow-up. For this analysis, partici-
pants who were overweight or obese, respectively, at
baseline were excluded. Adjustment was identical to the
multinomial logistic regression analyses.
All statistical analyses were performed by the SAS sta-
tistical software package version 9?1 (SAS Institute, Cary,
NC, USA, 2002). Analyses were performed separately for
men and women. Statistical tests were two-sided, and sig-
nificance level was set at P, 0?05.
Results
Participants who were lost to follow-up or did not report
their body weight in at least one of the follow-up rounds
(n 176) and participants who were predisposed to weight
change because of prevalent or incident cancer, myo-
cardial infarction, stroke or inflammatory bowel disease
(n 4904) were excluded, as well as the top and bottom
percentile of weight change (in percentage of baseline
weight, n 411). Finally, 20 049 participants (9182 men and
10 867 women) were included in the analysis.
Characteristics of the study population including dietary
intake of the fatty acids of interest are presented in Table 1.
Male participants were older and had a higher BMI than
female participants. The proportion of normal weight par-
ticipants at baseline was 55?3% in women, but only 32?0%
in men. On average, women gained, in a 5-year interval of
follow-up, 1?6% of baseline weight compared with 0?8% in
men. The proportion of participants with a baseline BMI
,25kg/m2 who became overweight during follow-up
(incident overweight) was 19?9% and 12?4% in men and
women, respectively. Around 5% of all men and women,
who had a BMI ,30kg/m2 at baseline, were obese at their
last follow-up (incident obese). Mean follow-up time was
6?5 years for both men and women.
Table 2 shows the distribution of the weight change
categories. Stable weight participants form the largest
group with a proportion of 50?7% and 42?7% in men and
women, respectively. About 18% of male and female
participants had a 5-year weight loss of more than 2?5%.
More women (39?8%) than men (31?1%) were char-
acterised by a 5-year weight gain. The proportion of men
and women who gained weight during follow-up
decreased with increasing baseline age. Age at baseline
and the percentage of weight change were significantly
inversely correlated in men and women (P, 0?0001).
The results of the linear regression analyses modelling
the influence of fatty acid intake on prospective weight
gain in men and women are presented in Table 3. Stearic
acid intake was significantly positively associated with
weight gain, yielding a weight gain .3% in men and
women per 10 g increment (.4% in normal weight par-
ticipants at baseline). For a better illustration, a participant
with a baseline body weight of 100 kg would gain an
additional 3 kg over 5 years by increasing stearic acid
intake by 10 g/d (at the expense of an equal proportion of
energy from carbohydrates); a participant with 70 kg
would increase body weight by approximately 2 kg.
In addition, the dietary intake of the n-6 PUFA linoleic
acid (only significant in women) and arachidonic acid
was significantly associated with prospective weight gain,
more pronounced in normal weight participants at
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baseline. Each 100mg increment of arachidonic acid
intake resulted in a 5-year weight gain of 0?62% and
0?42% in men and women with normal weight at base-
line, respectively. None of the other fatty acids were
significantly associated with weight gain in the linear
regression models. Total SFA, MUFA or PUFA intake was
not associated with weight gain (data not shown). Para-
meter estimates obtained from the repetition of the ana-
lyses using MUFA replacement models were quite similar
to those obtained from the carbohydrate replacement
models (data not shown).
Results of the multinomial logistic regression analysis
for male and female participants are presented in Tables 4
and 5, respectively. As seen in the linear regression
models, the risk estimates of the multinomial logistic
regression indicate a positive association between stearic
acid intake and weight gain, although not all were sta-
tistically significant. With regard to the dietary intake of
oleic acid, an inverse association was observed in male
(Table 4) and female (Table 5) participants who were
normal weight at baseline. In both men and women,
the dietary intake of linoleic acid (n-6) was positively
Table 1 Characteristics of male and female study participants (EPIC-Heidelberg)
Men Women
Mean or % SD Mean or % SD P value
n 9182 10 867
Age at baseline (years) 51?4 7?1 48?4 8?5 ,0?001*
Baseline body weight (kg) 83?3 12?0 67?7 12?2 ,0?001*
Baseline BMI (kg/m2) 26?8 3?6 25?2 4?5
Underweight (BMI, 18?5 kg/m2, %) 0?1 1?4
Normal weight (18?5#BMI,25 kg/m2, %) 32?0 55?3
Overweight (25#BMI,30 kg/m2, %) 51?1 29?3
Obese (BMI$30 kg/m2, %) 16?8 14?0 ,0?001-
Follow-up body weight-
-
(kg) 84?1 12?1 68?9 12?5 ,0?001*
Follow-up BMI (kg/m2) 27?1 3?7 25?7 4?7 ,0?001*
Five-year weight change (kg/5 years) 0?6 3?9 1?0 3?6 ,0?001*
Five-year weight change (%/5 years) 0?8 4?5 1?6 5?1 ,0?001*
Incident overweight (%) 19?9 12?4 ,0?001-
Incident obesity (%) 5?0 4?7 ,0?001-
Length of follow-up (years) 6?5 2?2 6?5 2?1 ,0?83*
Nutrient intake
Total energy (kcal/d)y 9204 3263 7237 2449 ,0?001 ||
Carbohydrates (g/d) 236?1 91?4 193?6 72?4 ,0?001||
Protein (g/d) 78?5 28?3 62?4 20?9 ,0?001||
Alcohol (g/d) 25?8 27?2 11?0 14?2 ,0?001||
Total fat (g/d) 84?6 37?7 69?8 28?7 ,0?001||
(% Energy) 34?4 6?0 36?1 5?6 ,0?001||
SFA (g/d) 35?1 16?8 29?6 13?3
(% Energy) 14?2 3?0 15?2 3?0 ,0?001||
Palmitic acid (g/d) 17?0 7?9 14?2 6?1 ,0?001||
Stearic acid (g/d) 7?6 4?2 6?1 3?2 ,0?001||
MUFA (g/d) 29?9 14?0 24?1 10?3
(% Energy) 12?1 2?4 12?4 2?2 ,0?001||
Oleic acid (g/d) 26?2 12?4 21?0 9?1 ,0?001||
PUFA (g/d) 14?0 6?3 11?5 4?9
(% Energy) 5?7 1?6 6?1 1?6 ,0?001||
n-6 PUFA
Linoleic acid (g/d) 11?9 5?5 9?9 4?3 ,0?001||
Arachidonic acid (mg/d) 201?5 105?9 143?5 81?1 ,0?001||
n-3 PUFA
ALA (g/d) 1?4 0?6 1?2 0?5 ,0?001||
EPA (mg/d) 102?6 128?8 69?7 106?3 ,0?001||
DHA (mg/d) 201?3 185?6 146?9 152?5 ,0?001||
Physically active z 27?0 24?1 ,0?001-
With university degree 38?6 25?3 ,0?001-
Habitual non-smokers 71?4 75?9
Habitual smokers 19?3 16?5 ,0?001-
Premenopausal 47?8
Perimenopausal 11?4
Postmenopausal 38?8
EPIC-Heidelberg, Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition; ALA, a-linolenic acid.
*t-test. Data are presented as mean and standard deviation, or percentage.
-Chi-square test.
-
-
Calibrated.
y1 kcal5 4?184 kJ.
||Wilcoxon rank-sum test.
zCombined occupational, cycling and sports activities.
Dietary fatty acid intake and weight change 1639
https://doi.org/10.1017/S1368980009993041
Downloaded from https:/www.cambridge.org/core. Open University Libraryy, on 15 Jan 2017 at 20:38:52, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
associated with small and large weight gain. Arachidonic
acid intake was positively associated with weight gain in
women only (Table 5). Dietary intake of the n-3 PUFA ALA
was significantly inversely associated with large weight
gain in women (Table 5), but not in men (Table 4). The
results for EPA and DHA were conflicting; although a
positive association was seen in men (Table 4), women in
the second tertile of dietary intake had a significantly
reduced risk of small weight gain (Table 5). When tertiles
of the total intake of SFA, MUFA and PUFA were analysed,
only the high intake of PUFA was significantly positively
associated with small and large weight gain in men and
women (data not shown). Re-evaluation of the analyses
with the MUFA replacement model did not alter the
Table 2 Distribution of categories of incident weight change by age groups in male and female participants of the EPIC-Heidelberg
cohort
,45 years 45–,55 years 55–65 years Total
Five-year weight change* category % n % n % n % n
Men (n 9182)
Weight loss (,22?5 %/5 years) 15?2 309 16?7 629 21?7 733 18?2 1671
Stable weight (62?5 %/5 years) 44?2 896 51?4 1942 53?7 1815 50?7 4653
Small gain (12?5% to 17?5 %/5 years) 31?9 647 25?2 953 20?3 685 24?9 2285
Large gain (.7?5 %/5 years) 8?6 175 6?7 252 4?3 146 6?2 573
Women (n 10 867)
Weight loss (,22?5 %/5 years) 15?9 667 17?8 648 19?7 597 17?6 1912
Stable weight (62?5 %/5 years) 39?4 1653 42?3 1536 47?6 1447 42?7 4636
Small gain (12?5% to 17?5 %/5 years) 31?0 1301 29?3 1064 25?5 774 28?9 3139
Large gain (.7?5 %/5 years) 13?7 575 10?6 385 7?2 220 10?9 1180
EPIC-Heidelberg, Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition.
*Difference of latest follow-up weight minus baseline weight, divided by baseline weight and years of follow-up, and multiplied by five.
Table 3 Association between energy-adjusted dietary fatty acid intake and prospective weight gain in male and female participants of the
EPIC-Heidelberg cohort* as assessed by multivariate linear regression models
All subjects Normal weight subjects at baseline-
b-
-
SE P value b-
-
SE P value
Men n 7511 n 2550
SFA
Palmitic acid (10 g/d)y 21?64 1?40 0?24 22?53 2?51 0?31
Stearic acid (10 g/d) 3?16 1?09 0?004 4?24 1?96 0?03
MUFA
Oleic acid (10 g/d) 20?02 0?24 0?95 20?22 0?40 0?57
PUFA
n-6
Linoleic acid (10 g/d) 0?31 0?20 0?12 0?59 0?34 0?08
Arachidonic acid (100 mg/d) 0?23 0?13 0?08 0?62 0?24 0?01
n-3
ALA (1 g/d) 0?08 0?26 0?74 20?07 0?45 0?88
DHA1EPA (100 mg/d)|| 0?06 0?05 0?22 0?06 0?08 0?45
Women n 8955 n 5090
SFA
Palmitic acid (10 g/d) 22?59 1?55 0?09 22?70 2?05 0?19
Stearic acid (10 g/d) 3?61 1?14 0?002 4?07 1?49 0?01
MUFA
Oleic acid (10 g/d) 20?25 0?24 0?29 20?28 0?30 0?35
PUFA
n-6
Linoleic acid (10 g/d) 0?62 0?19 0?00 0?71 0?25 0?00
Arachidonic acid (100 mg/d) 0?28 0?14 0?04 0?42 0?18 0?02
n-3
ALA (1 g/d) 20?03 0?26 0?91 20?19 0?34 0?57
DHA1EPA|| (100 mg/d) 20?06 0?05 0?23 20?01 0?06 0?83
EPIC-Heidelberg, Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition; ALA, a-linolenic acid.
*Subjects with weight loss (,22?5 %/5 years, n 1671 in men, n 1912 in women) excluded.
-Baseline BMI between 18?5 and 25 kg/m2 .
-
-
Adjusted for other PUFA, MUFA and SFA intakes (g/d), protein, alcohol intake (g/d), total energy intake (kcal/d (1 kcal5 4?184 kJ)), baseline weight (kg) and
height (cm), age at baseline (years), physical activity, education, smoking (never, habitual, new, quit), follow-up-time (years); in women aditionally adjusted for
menopausal status at baseline (premenopausal, perimenopausal, postmenopausal, surgical menopausal, missing).
yAll nutrients energy-adjusted by the residual method.
||Entered as sum because of high correlation (r. 0?97).
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risk estimates substantially (data not shown). The OR
obtained differed from those from the carbohydrate
replacement models by the second decimal only. In terms
of weight loss (data not shown), in the case of arachi-
donic acid, positive associations with weight gain were
reflected by the tendency of inverse associations with
weight loss (OR for weight loss, comparing highest v.
lowest tertile, was 0?80 (95% CI 0?64, 0?99) in men and
0?85 (95% CI 0?69, 1?04) in women). Dietary intake of
ALA, palmitic, stearic and acids was not associated with
weight loss.
The associations between fatty acid intake and incident
overweight and obesity, respectively, are shown in Fig. 1.
As in the multinomial logistic regression, stearic acid was
positively associated with weight gain. Compared with
participants in the lowest tertile, men in the highest tertile of
stearic acid intake had a significantly increased OR of
becoming overweight, while women in the same tertile had
a significantly increased OR of becoming incident obese.
The n-6 PUFA of linoleic and arachidonic acids were
positively associated with incident overweight and obesity,
especially in women. With regard to ALA, non-significant
Table 4 Odds ratios and 95 % confidence intervals for the association between energy-adjusted dietary fatty acid intake (in tertiles) and
small and large weight gain (v. stable weight) in male participants of the EPIC-Heidelberg cohort as assessed by multinomial logistic
regression models
All (n 7511) Normal weight subjects at baseline* (n 2550)
Small weight gain (n 2285) Large weight gain (n 573) Small weight gain (n 806) Large weight gain (n 251)
Men OR 95 % CI- OR 95 % CI- OR 95 % CI- OR 95 % CI-
SFA
Palmitic acid (g/d)-
-
,12?8 1?00 1?00 1?00 1?00
12?8–15?1 1?17 0?94, 1?47 1?33 0?89, 1?97 0?95 0?64, 1?40 1?14 0?62, 2?13
.15?1 1?27 0?91, 1?75 1?40 0?79, 2?48 1?01 0?58, 1?78 1?11 0?46, 2?70
Ptrend 0?18 0?32 1?00 0?91
Stearic acid (g/d)
,5?5 1?00 1?00 1?00 1?00
5?5–6?6 0?85 0?70, 1?02 0?92 0?66, 1?28 0?99 0?72, 1?35 1?23 0?74, 2?03
.6?6 1?06 0?83, 1?35 1?25 0?82, 1?91 1?21 0?80, 1?82 1?85 0?98, 3?48
Ptrend 0?47 0?19 0?29 0?04
MUFA
Oleic acid (g/d)
,20?00 1?00 1?00 1?00 1?00
20?0–23?2 0?98 0?83, 1?16 1?12 0?83, 1?51 0?89 0?67, 1?18 0?87 0?56, 1?38
.23?2 0?89 0?71, 1?11 0?93 0?63, 1?37 0?82 0?57, 1?17 0?56 0?31, 1?00
Ptrend 0?32 0?66 0?29 0?04
PUFA
n-6
Linoleic acid (g/d)
,8?6 1?00 1?00 1?00 1?00
8?6–10?9 1?11 0?97, 1?28 1?09 0?85, 1?40 1?03 0?81, 1?30 1?23 0?83, 1?82
.10?9 1?18 1?00, 1?39 1?27 0?94, 1?70 1?19 0?90, 1?58 1?64 1?04, 2?61
Ptrend 0?08 0?11 0?22 0?03
Arachidonic acid (g/d)
,0?14 1?00 1?00 1?00 1?00
0?14–0?19 1?01 0?87, 1?17 0?82 0?62, 1?07 1?09 0?84, 1?40 0?91 0?60, 1?36
.0?19 0?97 0?80, 1?17 0?81 0?58, 1?14 1?00 0?71, 1?39 0?85 0?49, 1?46
Ptrend 0?64 0?27 0?95 0?58
n-3
ALA (g/d)
,1?04 1?00 1?00 1?00 1?00
1?04–1?23 0?95 0?82, 1?10 0?95 0?73, 1?24 1?11 0?85, 1?44 0?88 0?57, 1?35
.1?23 0?97 0?81, 1?16 1?12 0?83, 1?53 1?07 0?78, 1?46 0?86 0?52, 1?43
Ptrend 0?82 0?36 0?79 0?62
EPA1DHA (g/d)y
,0?16 1?00 1?00 1?00 1?00
0?16–0?28 1?06 0?92, 1?21 1?23 0?97, 1?57 1?17 0?93, 1?47 1?25 0?86, 1?82
.0?28 1?17 0?99, 1?37 1?43 1?07, 1?90 1?03 0?78, 1?36 1?34 0?85, 2?12
Ptrend 0?05 0?02 0?92 0?22
EPIC-Heidelberg, Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition; ALA, a-linolenic acid.
*Baseline BMI between 18?5 and 25 kg/m2 .
-Adjusted for other PUFA, MUFA, SFA intakes, protein, alcohol intake, total energy intake, baseline weight (kg) and height (cm), age at baseline (years),
physical activity, education, smoking (never, habitual, new, quit), follow-up time (years) and menopausal status in women.
-
-
All nutrients energy-adjusted by the residual method.
yEntered as sum because of high correlation (r. 0?97).
Bold values are estimates significant at P, 0?05.
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inverse associations between incident overweight and
obesity were observed in both men and women.
Discussion
In the present study, the effects of dietary fatty acid
intakes on long-term weight change were investigated in
a prospective setting. Weight-promoting effects were
observed for stearic, linoleic and arachidonic acids in men
and women, whereas ALA showed inverse associations
with weight gain in women. Oleic acid intake was
inversely associated with prospective weight gain in the
multinomial logistic regression, especially after restric-
tion to participants who were normal weight at baseline.
No clear associations were observed for palmitic acid and
the sum of EPA and DHA.
Several biological mechanisms may help in explaining
the differential effects of fatty acids on weight develop-
ment in adults, as observed in the present study. Fatty
acids differ slightly with respect to their energy content.
The order of fatty acids according to their energy content
is linolenic acid (38?7 kJ/g), linoleic (39?0 kJ/g),
palmitic acid (39?2 kJ/g),oleic (39?4 kJ/g), stearic acid
Table 5 Odds ratios and 95 % confidence intervals for the association between energy-adjusted dietary fatty acid intake (in tertiles) and
small and large weight gain (v. stable weight) in female participants of the EPIC-Heidelberg cohort as assessed by multinomial logistic
regression models
All (n 8955) Normal weight subjects at baseline* (n 5090)
Small weight gain (n 3139) Large weight gain (n 1180) Small weight gain (n 1689) Large weight gain (n 581)
Women OR 95 % CI- OR 95 % CI- OR 95 % CI- OR 95 % CI-
SFA
Palmitic acid (g/d)-
-
,12?8 1?00 1?00 1?00 1?00
12?8–15?1 1?00 0?82, 1?21 1?07 0?81, 1?42 1?06 0?82, 1?38 1?17 0?79, 1?72
.15?1 0?93 0?70, 1?24 1?01 0?67, 1?52 1?29 0?88, 1?89 1?23 0?69, 2?17
Ptrend 0?56 0?99 0?18 0?52
Stearic acid (g/d)
,5?5 1?00 1?00 1?00 1?00
5?5–6?6 1?07 0?92, 1?26 1?26 0?99, 1?59 1?07 0?86, 1?32 1?26 0?91, 1?74
.6?6 1?16 0?94, 1?43 1?39 1?03, 1?88 1?08 0?82, 1?42 1?50 1?00, 2?26
Ptrend 0?15 0?03 0?63 0?04
MUFA
Oleic acid (g/d)
,20?5 1?00 1?00 1?00 1?00
20?5–23?8 0?91 0?79, 1?05 0?95 0?77, 1?17 0?86 0?71, 1?03 0?93 0?70, 1?24
.23?8 0?86 0?71, 1?02 0?89 0?69, 1?16 0?76 0?60, 0?96 0?78 0?55, 1?10
Ptrend 0?10 0?37 0?02 0?14
PUFA
n-6
Linoleic acid (g/d)
,8?9 1?00 1?00 1?00 1?00
8?9–11?2 1?06 0?94, 1?20 1?10 0?92, 1?32 1?16 0?99, 1?36 1?12 0?88, 1?43
.11?2 1?24 1?08, 1?43 1?56 1?27, 1?90 1?36 1?13, 1?64 1?65 1?25, 2?18
Ptrend 0?00 ,0?00 0?00 0?00
Arachidonic acid (g/d)
,0?12 1?00 1?00 1?00 1?00
0?12–0?17 1?16 1?02, 1?33 1?10 0?90, 1?35 1?23 1?04, 1?47 0?92 0?70, 1?21
.0?17 1?30 1?10, 1?54 1?23 0?96, 1?58 1?40 1?11, 1?76 1?15 0?81, 1?62
Ptrend 0?01 0?16 0?01 0?50
n-3
ALA (g/d)
,1?1 1?00 1?00 1?00 1?00
1?1–1?3 0?88 0?78, 1?00 0?85 0?71, 1?02 0?90 0?77, 1?07 0?88 0?68, 1?13
.1?3 0?88 0?76, 1?02 0?80 0?65, 0?99 0?86 0?71, 1?04 0?82 0?62, 1?10
Ptrend 0?11 0?05 0?14 0?20
EPA1DHA (g/d)y
,0?15 1?00 1?00 1?00 1?00
0?15–0?25 0?81 0?72, 0?92 0?87 0?72, 1?03 0?82 0?70, 0?97 0?83 0?65, 1?06
.0?25 0?90 0?78, 1?05 0?94 0?76, 1?16 0?89 0?73, 1?08 0?97 0?72, 1?30
Ptrend 0?40 0?73 0?36 0?93
EPIC-Heidelberg, Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition; ALA, a-linolenic acid.
*Baseline BMI between 18?5 and 25 kg/m2 .
-Adjusted for other PUFA, MUFA, SFA intakes, protein, alcohol intake, total energy intake, baseline weight (kg) and height (cm), age at baseline (years),
physical activity, education, smoking (never, habitual, new, quit), follow-up time (years) and menopausal status in women.
-
-
All nutrients energy-adjusted by the residual method.
yEntered as sum because of high correlation (r. 0?97).
Bold values are estimates significant at P, 0?05.
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(40?0 kJ/g), arachidonic acid (40?5 kJ/g)(23). However,
the metabolisable energy depends on the intestinal
absorption, which is lower for stearic acid than for other
fatty acids such as palmitic, oleic or linoleic acid(24,25).
Considering that some fatty acids are consumed in very
small amounts, differences in energy content and bio-
availability cannot be the only explanation for the
observed effects. Furthermore, in the present study,
dietary fatty acid intake was adjusted for energy intake, so
that differences in energy content are rather unlikely
to explain the observed results. A diet with a high pro-
portion of PUFA has been shown to induce a higher
thermogenic effect in man than a diet high in SFA(10).
The oxidation rates of fatty acids depend on the chain
length and the degree of saturation. In man, the order
of oxidation rates from highest to lowest was observed
as follows: ALA. linoleic acid.oleic acid.palmitoleic
acid. stearic acid(12). Accordingly, a diet high in satu-
rated fats (such as stearic acid) with a low oxidation rate
might be more prone to lead to weight gain than a diet
rich in polyunsaturated fats (such as ALA) with a higher
oxidation rate. In a study on rats, animals on a diet high in
beef tallow (saturated fat) accumulated more body fat
than animals on a diet high in safflower oil (poly-
unsaturated fat), which was related to a decrease in
sympathetic activity in the beef tallow diet(13). In addition
to effects directly related to the efficiency of energy sto-
rage, certain fatty acids, (i.e. n-3 and n-6 PUFA) have
been shown to act as transcription factors influencing
the expression of genes important in fat metabolism.
Especially, n-3 fatty acids (ALA, EPA and DHA) promote
the expression of genes involved in fat oxidation and
thermogenesis, yielding decreased body fat deposition
and improved glucose clearance(16). Fatty acids may also
exert different effects on postprandial appetite. In an
experimental study on normal weight men, food intake
was lowest after intestinal infusion of linoleic acid than
that of oleic or stearic acid(26). In contrast, in a study in
which test meals with different fatty acid compositions
were given to overweight men, no differences regarding
subsequent energy intake were observed(27).
In the present study, dietary intake of stearic acid was
positively associated with weight gain, especially in the
linear regression approach. This finding seems plausible
in the context of the low oxidation rate (i.e. fat is more
prone to be stored in fat tissue) and relatively high energy
content of stearic acid(12). However, no association was
found for palmitic acid, which has an oxidation rate only
slightly above stearic acid and provides minimally lower
energy content. Neither prospective nor cross-sectional
analyses have been conducted in order to explicitly
investigate the effect of habitual intake of these two SFA
on BMI or weight gain.
Oleic acid, contributing 90% to total MUFA intake, was
inversely associated with prospective weight gain in the
multinomial logistic regression restricted to participants
who were normal weight at baseline. There are no
directly comparable studies investigating oleic acid intake
and weight change prospectively. In a prospective cohort
study from Spain (SUN study), baseline consumption of
olive oil (70% oleic acid) was associated with a lower
likelihood of weight gain, although not statistically sig-
nificant(28). The comparability of Bes-Rastrollo et al.’s(28)
study to the present study might be impaired due to dif-
fering dietary habits in Spain and Germany, especially in
terms of olive oil consumption, which determine high
intake of oleic acid.
The n-6 PUFA linoleic and arachidonic acids showed
weight-promoting effects in the linear regression as well
as in the multinomial logistic regression models. In the
Nurses’ Health Study, linoleic acid intake was positively
correlated with BMI(15). To our knowledge, the effect of
dietary arachidonic acid intake on prospective weight
change has not been investigated in an epidemiological
study so far. However, in the EPIC-Potsdam study, dietary
intake of meat, the major food source of arachidonic acid,
was associated with increased risk of a large, 2-year
weight gain in women(29).
Reduced risks of small and large weight gain were
observed in women with high ALA intake, significantly so
for large weight gain. Although an inverse association
between dietary intake of ALA and weight gain has not
been observed in an epidemiological study so far, this
finding seems plausible in the context of the high oxidation
rate of ALA and its potential activity as a transcription factor
enhancing fat oxidation rates and thermogenesis.
Here, the applied isoenergetic models represent the
effect of substituting energy from carbohydrates by the
same amount of energy provided by a certain fatty acid
(carbohydrate replacement model). Increased intake of a
certain fatty acid in such a model implies the proportion
of energy provided by fat to increase. A high percentage
of energy from fat has been associated with weight gain
in several epidemiological studies(30). In this context,
increased intake of any fatty acid in the carbohydrate
replacement model would be expected to promote weight
gain due to the implied higher proportion of energy from
fat. However, the quite similar results obtained from the
MUFA replacement models show that certain fatty acids
also affect weight change when the percentage of energy
from fat remains constant (i.e. substituting energy from
MUFA by energy from the fatty acid of interest).
The linear and the multinomial logistic regression
approaches yielded fairly consistent results. The definition
of incident overweight/obesity is an alternative approach to
study weight change longitudinally, with a more health-
related focus. The consistent results of the analysis of
incident overweight/obesity, as compared to weight gain
per se, argue for a factor associated with weight gain to be
most likely also related to incident overweight or obesity.
Apart from the fact that our findings require con-
firmation by other studies, the conclusion in terms of
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dietary advice for the prevention of weight gain by
controlled fatty acid intake would include a reduced
consumption of meat and dairy products (low intake
of arachidonic and stearic acids) and a higher consump-
tion of plant food rich in ALA (e.g. nuts or rapeseed
oil)(31). Such advice would be in agreement with existing
dietary guidelines for the prevention of chronic disease
occurrence.
Limitations
Several limitations of the present study should be noted.
First, the ability to assess absolute intake of individual
dietary fatty acids by means of an FFQ is limited. Fur-
thermore, by using dietary intake data ascertained by FFQ
at baseline in this prospective analysis, we assume that
dietary habits remain stable over time. This assumption,
however, seems justified, as moderate-to-good long-term
reproducibility of the FFQ data and fair agreement of
individual classification by food groups and nutrients
between baseline and follow-up were observed in a
comparison of the two dietary assessments in our study
population(35). The validity of fat intake assessment by the
EPIC-Heidelberg FFQ has been evaluated by using twelve
24 h dietary recalls as a reference method. The resulting
adjusted correlation coefficients were 0?75, 0?51 and 0?43
for PUFA, MUFA and SFA, respectively(17). However, the
validity of specific fatty acid intake has not been addres-
sed in the present validation study. Thus, it can only be
assumed that the validity of specific fatty acid data is
similar to that observed in subgroups of comparable
cohort studies by using weighed dietary records(32–34) or
subcutaneous fat aspirates(34) as reference methods. In a
British validation study of an FFQ that included a greater
detail of foods from which the majority of dietary fatty
acids are obtained, correlation coefficients of energy-
adjusted fatty acid intake with 7 d weighed records were
0?77 for palmitic, 0?70 for stearic, 0?20 for oleic, 0?24 for
linoleic and 0?70 for arachidonic acids(32). Similarly, in a
Japanese validation study of a 138-item FFQ with 28 d
weighed records, relatively high correlations were
observed for stearic and palmitic acids (0?61 and 0?63,
respectively), whereas correlation coefficients for PUFA
were rather low, between 0?27 (linolenic acid) and 0?38
(EPA)(33). Overall, it cannot be dismissed that the fatty
acid intake data in the present study require cautious
interpretation, also because databases on the fatty acid
composition of food are limited in precision. Never-
theless, we hope that the results of this hypothesis-driven
analysis stimulate further research on this question, ide-
ally involving studies applying more precise methods of
dietary fatty acid intake measurement.
Also, the validity and precision of the self-reported
body weight at follow-up are limited. However, the self-
reported data were calibrated by a method using BMI-
and sex-specific equations derived from a 7% subsample
to reduce the misclassification error.
It has been shown that the accuracy of weight(36) and
diet(37) reports depends on BMI. Therefore, the results of the
subanalysis restricted to participants with normal weight at
baseline may be regarded as more reliable than the analysis
of the total cohort. Results from the full analysis and the
subanalysis were, however, fairly comparable.
Here, the applied index ranking participants in terms
of their physical activity combining occupational and
leisure-time physical activity has been validated using
accelerometers(38) and heart rate monitoring(20) as reference
instruments, showing acceptable agreement. Nevertheless,
a more precise instrument to measure physical activity
would have been desirable.
Conclusion
Here, the observed associations of fatty acid intake with
prospective weight change lack comparable analyses
from other prospective studies, and even experimental
studies on human subjects focusing on specific fatty acids
and their effect on weight change are scarce. Therefore,
further studies on this issue are strongly warranted before
detailed dietary recommendations focussing on the pre-
vention of adult weight gain can be given.
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